A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

News | Ultrasound Imaging | October 28, 2020
Northwestern Medicine Introduces Artificial Intelligence to Improve Ultrasound Imaging
October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Health...
read more
Vinai Gondi, M.D., the Director of Research at the Northwestern Medicine Chicago Proton Center, Co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

Vinai Gondi, M.D., director of research at the Northwestern Medicine Chicago Proton Center, co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

News | Intensity Modulated Radiation Therapy (IMRT) | October 27, 2020
Photon IMRT Treatment Group Displays No Significant Survival Difference Between Arms
October 27, 2020 — A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical...
read more
Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Feature | Magnetic Resonance Imaging (MRI) | October 27, 2020
MRI Can Be Safely Performed in Patients With Pacemakers and ICDs
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR...
read more
"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial" was presented by Jing Li, M.D., The University of Texas MD Anderson Cancer Center, at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
Radiosurgery Reduces Cognitive Decline Without Compromising Survival for Patients with 4+ Brain Metastases
October 26, 2020 — Results of a new randomized phase III trial suggest that stereotactic radiosurgery (SRS) should...
read more
"Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial," presented by Shankar Siva, Ph.D., Peter MacCallum Cancer Centre, was presented at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
Group Trial Bolsters Case for Stereotactic Radiation Therapy for Tumors that Travel to the Lungs
October 26, 2020 — A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the case...
read more
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging | October 26, 2020
Adding Advanced PET Scans to Radiation Treatment Plans for Prostate Cancer Increases Failure-free Survival Rates
October 26, 2020 — Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation...
read more
A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases was presented by Arjun Sahgal, M.D., University of Toronto, today at ASTRO20
News | Radiation Therapy | October 26, 2020
Treating Spinal Metastases with Fewer and Higher Doses of Radiation Reduces Pain More Effectively
October 26, 2020 — A new study shows using fewer and higher doses of high-precision radiation therapy is a more...
read more
Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
FDA Clears YSIO X.pree Intelligent Radiography System From Siemens Healthineers
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the YSIO X....
read more
Videos | Artificial Intelligence | October 26, 2020
VIDEO: AI Features on the GE Voluson Swift Ultrasound System
GE Healthcare is highlighting artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform...
read more
iCAD showcasing expanded Xoft Platform including Single-Fraction IORT Solution for brain and early-stage breast cancer tumors
News | Brachytherapy Systems | October 26, 2020
New Research Presented at ASTRO20 Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers
October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic...
read more
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will be...
read more
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
Proton Therapy for Lung Cancer May Help Reduce Risk of Heart Diseases
October 25, 2020 — Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced...
read more
RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, will present eight clinical abstracts evaluating the use of its novel technology at the virtual American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, Oct. 24-28.
News | Radiation Therapy | October 25, 2020
RefleXion Highlights New Research at ASTRO20 Evaluating Feasibility of Biology-guided Radiotherapy to Treat Metastatic Cancer
October 25, 2020 —RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a...
read more
Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
Philips Showcases Integrated Radiation Oncology Solutions to Streamline Diagnosis and Treatment at ASTRO20
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in radiation...
read more
During the 2020 ASTRO Annual Meeting, taking place online October 23-29, Sun Nuclear is highlighting a range of solutions clinics can leverage to ensure continuity for their Quality Management programs.
News | Quality Assurance (QA) | October 25, 2020
Sun Nuclear Presents Updated and Comprehensive Quality Management Solutions at ASTRO20
October 25, 2020 — During the 2020 ASTRO Annual Meeting, taking place online October 23-29, Sun Nuclear is highlighting...
read more
A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how patients whose prostate cancer recurs after prostatectomy are treated. The study will be featured in both the plenary session and press program of the American Society for Radiation Oncology (ASTRO) Annual Meeting on Monday, October 26.
News | Prostate Cancer | October 24, 2020
ASTRO Highlights Winship Study Showing Increased Failure-free Survival in Prostate Cancer
October 24, 2020 — A study from Winship Cancer Institute of Emory University (Winship) has the potential to change how...
read more
Conference programming for ASTRO20 began today, and runs through October 29 #ASTRO20
News | ASTRO | October 24, 2020
ASTRO's Exhibit Hall Only Day Draws Over 1,000 Attendees
October 24, 2020 — The American Society of Radiation Oncology's (ASTRO) 62nd Annual Meeting launched its Exhibit Hall...
read more
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
Canon Medical Showcases New Aquilion Exceed LB CT System at ASTRO20
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S. this year alone. With a...
read more
The research evaluates the feasibility of biology-guided radiotherapy to treat metastatic cancer
News | Radiation Therapy | October 24, 2020
RefleXion Highlights New Research at ASTRO 2020
October 24, 2020 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as...
read more
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
FFR-CT Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography
October 22, 2020 – In the FORECAST randomized clinical trial, the use of fractional flow reserve (FFR) derived from...
read more
© Copyright Wainscot Media. All Rights Reserved.